These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12672261)

  • 1. Treatment of aggression in children and adolescents with autism and conduct disorder.
    McDougle CJ; Stigler KA; Posey DJ
    J Clin Psychiatry; 2003; 64 Suppl 4():16-25. PubMed ID: 12672261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacologic treatment of aggression in children and adolescents.
    Ruths S; Steiner H
    Pediatr Ann; 2004 May; 33(5):318-27. PubMed ID: 15162638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.
    Posey DJ; McDougle CJ
    Harv Rev Psychiatry; 2000; 8(2):45-63. PubMed ID: 10902094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of children and adolescents with pervasive developmental disorders.
    Hanft A; Hendren RL
    Essent Psychopharmacol; 2004; 6(1):12-24. PubMed ID: 15612651
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacotherapy of Aggression in Child and Adolescent Psychiatric Disorders.
    Gurnani T; Ivanov I; Newcorn JH
    J Child Adolesc Psychopharmacol; 2016 Feb; 26(1):65-73. PubMed ID: 26881859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology of autistic spectrum disorders in children and adolescents.
    Nazeer A
    Pediatr Clin North Am; 2011 Feb; 58(1):85-97, x. PubMed ID: 21281850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapeutic management of autism.
    Posey DJ; McDougle CJ
    Expert Opin Pharmacother; 2001 Apr; 2(4):587-600. PubMed ID: 11336609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug treatment of conduct disorder in young people.
    Gérardin P; Cohen D; Mazet P; Flament MF
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):361-70. PubMed ID: 12208553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
    Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
    J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication?
    Balia C; Carucci S; Coghill D; Zuddas A
    Neurosci Biobehav Rev; 2018 Aug; 91():218-238. PubMed ID: 28137460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of pharmacotherapy for autism spectrum disorders.
    Myers SM
    Expert Opin Pharmacother; 2007 Aug; 8(11):1579-603. PubMed ID: 17685878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacotherapy for conduct disorder in children and adolescents].
    Levy T; Bloch Y
    Harefuah; 2012 Jul; 151(7):421-6, 435, 434. PubMed ID: 23002695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability.
    Parikh MS; Kolevzon A; Hollander E
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):157-78. PubMed ID: 18439113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted treatments for symptom domains in child and adolescent autism.
    Hollander E; Phillips AT; Yeh CC
    Lancet; 2003 Aug; 362(9385):732-4. PubMed ID: 12957098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychopharmacology of autism spectrum disorders].
    Poustka L; Banaschewski T; Poustka F
    Nervenarzt; 2011 May; 82(5):582-9. PubMed ID: 21484169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.
    Malone RP; Gratz SS; Delaney MA; Hyman SB
    CNS Drugs; 2005; 19(11):923-34. PubMed ID: 16268664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic Medication Use in Children and Adolescents With Down Syndrome.
    Downes A; Anixt JS; Esbensen AJ; Wiley S; Meinzen-Derr J
    J Dev Behav Pediatr; 2015 Oct; 36(8):613-9. PubMed ID: 26035141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacologic treatment of pathologic aggression.
    Fava M
    Psychiatr Clin North Am; 1997 Jun; 20(2):427-51. PubMed ID: 9196923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.